TY - JOUR
T1 - Obstetric embolotherapy
T2 - Effect on menses and pregnancy
AU - Stancato-Pasik, Agata
AU - Mitty, Harold A.
AU - Richard, Howard M.
AU - Eshkar, Noam
PY - 1997/9
Y1 - 1997/9
N2 - PURPOSE: To determine the long-term effects of uterine embolotherapy with gelatin sponge pledgets on menses and fertility. MATERIALS AND METHODS: Between June 1990 and December 1995, 17 women (aged 20-44 years) with obstetric hemorrhage underwent selective gelatin sponge pledget embolization of uterine vessels. Gynecologic information in the 12 women who did not undergo hysterectomy was obtained by means of direct communication or from the patients' physicians. RESULTS: In 11 (92%) of the 12 women, normal menses resumed within 2-5 months of the procedure. There were no complications related to embolotherapy. The follow-up period was 1-6 years. All three patients who desired to conceive had full-term, healthy newborns. The only patient who is amenorrheic is currently receiving medroxyprogesterone acetate; her ultimate menstrual and fertility status cannot yet be determined. CONCLUSION: Selective embolization of the uterine vessels with gelatin sponge pledgets is a safe and effective method of managing pregnancy- related hemorrhage. Our results suggest that women who undergo this procedure can expect to have a return of normal menses with no adverse effect on fertility.
AB - PURPOSE: To determine the long-term effects of uterine embolotherapy with gelatin sponge pledgets on menses and fertility. MATERIALS AND METHODS: Between June 1990 and December 1995, 17 women (aged 20-44 years) with obstetric hemorrhage underwent selective gelatin sponge pledget embolization of uterine vessels. Gynecologic information in the 12 women who did not undergo hysterectomy was obtained by means of direct communication or from the patients' physicians. RESULTS: In 11 (92%) of the 12 women, normal menses resumed within 2-5 months of the procedure. There were no complications related to embolotherapy. The follow-up period was 1-6 years. All three patients who desired to conceive had full-term, healthy newborns. The only patient who is amenorrheic is currently receiving medroxyprogesterone acetate; her ultimate menstrual and fertility status cannot yet be determined. CONCLUSION: Selective embolization of the uterine vessels with gelatin sponge pledgets is a safe and effective method of managing pregnancy- related hemorrhage. Our results suggest that women who undergo this procedure can expect to have a return of normal menses with no adverse effect on fertility.
KW - Arteries, therapeutic blockade
KW - Pelvic organs, hemorrhage
KW - Pregnancy, complications
UR - http://www.scopus.com/inward/record.url?scp=0030766101&partnerID=8YFLogxK
U2 - 10.1148/radiology.204.3.9280261
DO - 10.1148/radiology.204.3.9280261
M3 - Article
C2 - 9280261
AN - SCOPUS:0030766101
SN - 0033-8419
VL - 204
SP - 791
EP - 793
JO - Radiology
JF - Radiology
IS - 3
ER -